Show simple item record

dc.contributor.authorSimpson, Moanaen_US
dc.contributor.authorFechner, Gregoryen_US
dc.contributor.authorBaell, Jonathanen_US
dc.contributor.authorStreet, Ianen_US
dc.contributor.authorCamp, Daviden_US
dc.date.accessioned2017-04-24T08:24:40Z
dc.date.available2017-04-24T08:24:40Z
dc.date.issued2008en_US
dc.date.modified2009-12-21T03:12:02Z
dc.identifier.urihttp://hdl.handle.net/10072/27808
dc.description.abstractAccessing compound libraries to facilitate biomedical research in the Australasian region Moana Simpson1, Jonathan Baell2, Ian Street2 and David Camp1* 1Queensland Compound Library Eskitis Institute, Griffith University Nathan QLD 4111 2Cancer Therapeutics CRC Pty Ltd 4 Research Avenue Bundoora VIC 3083 The completion of the Human Genome Project has provided an abundance of new targets for biological evaluation. Small organic molecules (compounds with a molecular weight < 500 Daltons) can be used as probes and leads to provide biological and therapeutic insights respectively. They are complementary to nucleic acid-based tools in that they target the gene product, typically a protein, rather than the gene or mRNA; have virtually limitless structural diversity; can act as agonists or antagonists and exquisitely affect a particular target for defined periods of time.[1] Unfortunately, it remains difficult to predict exactly which small molecules would be the most effective at modulating a given biological process or disease state. The medium- to high-throughput screening of novel and diverse compound libraries is being used increasingly more often to help overcome this limitation. The Queensland Compound Library (QCL) was recently established as a national small molecule repository to give biomedical researchers in the Australasian region the same opportunity to screen their targets against a range of novel and known compounds as is already the case in Europe and North America.[2] The Cancer Therapeutics CRC (CTx) is one example of an organisation that has utilised the QCL's expertise in compound management to facilitate its goal of drug discovery against a range of cancer-related targets. 1. Austin CP, Brady LS, Insel TR, Collins FS: NIH Molecular Libraries Initiative. Science 2004, 306:1138-1139. 2. Camp D, Avery V, Street I, Quinn RJ: Progress toward establishing an open access molecular screening capability in the Australasian region. ACS Chem Biol 2007, 2:764-767.en_US
dc.description.publicationstatusYesen_AU
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherNo data provideden_US
dc.publisher.urihttp://www.ahmrcongress.org.au/index.php?option=com_content&task=view&id=97&Itemid=105en_AU
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofconferencenameAHMRC Congress 2008en_US
dc.relation.ispartofconferencetitleThe Queensland Compounbd Library - facilitating biomedical research in the Australasian regionen_US
dc.relation.ispartofdatefrom2008-11-16en_US
dc.relation.ispartofdateto2008-11-21en_US
dc.relation.ispartoflocationBrisbane, Australiaen_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchBiochemistry and Cell Biology not elsewhere classifieden_US
dc.subject.fieldofresearchcode060199en_US
dc.titleThe Queensland Compound Library - Facilitating biomedical research in the Australasian regionen_US
dc.typeConference outputen_US
dc.type.descriptionE3 - Conference Publications (Extract Paper)en_US
dc.type.codeE - Conference Publicationsen_US
gro.facultyGriffith Sciences, Griffith Institute for Drug Discoveryen_US
gro.date.issued2008
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record